In the CHAPAS-3 trial , HIV-infected children ( ART-naive or on d4T for 2 years without clinical lipodystrophy ) were randomized to d4T , abacavir or zidovudine with lamivudine ( 3TC ) plus a non-nucleoside reverse transcriptase inhibitor .